Future Journal of Pharmaceutical Sciences,
Год журнала:
2024,
Номер
10(1)
Опубликована: Ноя. 14, 2024
Abstract
Background
Conventional
therapies
in
cancer
treatment
face
challenges
including
drug
resistance,
lack
of
specificity,
and
severe
adverse
reactions.
This
study
explores
the
potential
liposomal
transdermal
delivery
systems
as
an
alternative
to
current
with
improved
BA
PK.
The
objective
was
formulate
gefitinib
liposomes
by
thin
film
hydration
technique
(TFH)
using
lipoid
S100.
A
central
composite
design
(CCD)
used
develop
optimize
GEF-LIP-TDDs
analyze
optimum
concentrations
selected
variables
(phospholipid,
cholesterol)
formation.
model
fitting
performed
Design-Expert
(Stat-Ease,
Ver
13).
GEF
were
evaluated
for
%EE,
mean
particle
size
PDI.
optimized
fabricated
a
patch
mercury
substrate
method
%drug
content,
vitro
diffusion,
vivo
biodistribution
(PK
BA),
skin
irritation
studies
female
Albino
Wistar
rats.
stability
also
assessed
3
months.
Results
CCD
significant
F
-value
37.97,
P
0.0500
R
2
0.9644.
average
vesicle
size,
PDI,
ZP
GEF-LIPs
(F1–F13)
found
be
between
112.8
373.7
nm,
0.186
0.510
−
3.69
82.2
mV,
respectively.
F3-GEF-LIP
exhibited
96.07
46.06
PDI
0.423.
demonstrated
exceptional
%EE
(97.79)
sustained
release
effect
(%CDR,
83.32)
following
diffusion-controlled
mechanism.
TEM
images
confirmed
multivesicular
type
(MVV,
<
100
nm).
Importantly,
F3-GEF-LIP-TD
showed
no
signs
edema
similar
pure
higher
liver
(
p
0.05).
observed
74.05
±
0.11%
comparison
oral
GEF-LIP
(65.25
0.08%)
(58.10
0.17%).
Conclusion
TFH
offers
stable
high
reproducibility.
Our
findings
imply
that
GEF-LIP-TD
provides
enhanced
tissue
distribution
can
considered
substitution
orals
or
combination
treating
breast
cancer.
Lipoid
S100
is
lipid
developing
nanoliposomes.
Graphical
abstract
Life Sciences,
Год журнала:
2024,
Номер
352, С. 122899 - 122899
Опубликована: Июль 9, 2024
This
comprehensive
review
provides
an
in-depth
analysis
of
how
nanotechnology
has
revolutionized
cancer
theragnostic,
which
combines
diagnostic
and
therapeutic
methods
to
customize
treatment.
The
study
examines
the
unique
attributes,
uses,
difficulties
linked
different
types
nanoparticles,
including
gold,
iron
oxide,
silica,
Quantum
dots,
Carbon
nanotubes,
liposomes,
in
context
In
addition,
paper
progression
nanotheranostics,
emphasizing
its
uses
precise
medication
administration,
photothermal
therapy,
sophisticated
such
as
MRI,
CT,
fluorescence
imaging.
Moreover,
article
highlights
capacity
nanoparticles
improve
effectiveness
drugs,
reduce
overall
toxicity
body,
open
up
new
possibilities
for
treating
by
releasing
drugs
a
controlled
manner
targeting
specific
areas.
Furthermore,
it
tackles
concerns
regarding
compatibility
their
potential
harmful
effects,
significance
continuous
nanotherapeutic
use
medical
treatments.
finishes
outlining
future
applications
predictive
oncology
customized
medicine.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(11), С. 5842 - 5842
Опубликована: Май 27, 2024
This
study
provides
a
brief
discussion
of
the
major
nanopharmaceuticals
formulations
as
well
impact
nanotechnology
on
future
pharmaceuticals.
Effective
and
eco-friendly
strategies
biofabrication
are
also
highlighted.
Modern
approaches
to
designing
pharmaceutical
nanoformulations
(e.g.,
3D
printing,
Phyto-Nanotechnology,
Biomimetics/Bioinspiration,
etc.)
outlined.
paper
discusses
need
use
natural
resources
for
“green”
design
new
with
therapeutic
efficiency.
Nanopharmaceuticals
research
is
still
in
its
early
stages,
preparation
nanomaterials
must
be
carefully
considered.
Therefore,
safety
long-term
effects
not
overlooked.
The
testing
represents
an
essential
point
their
further
applications.
Vegetal
scaffolds
obtained
by
decellularizing
plant
leaves
represent
valuable,
bioinspired
model
nanopharmaceutical
that
avoids
using
animals.
Nanoformulations
critical
various
fields,
especially
pharmacy,
medicine,
agriculture,
material
science,
due
unique
properties
advantages
over
conventional
allows
improved
solubility,
bioavailability,
targeted
drug
delivery,
controlled
release,
reduced
toxicity.
have
transitioned
from
experimental
stages
being
vital
component
clinical
practice,
significantly
improving
outcomes
medical
fields
cancer
treatment,
infectious
diseases,
neurological
disorders,
personalized
advanced
diagnostics.
Here
key
points
highlighting
importance.
significant
challenges,
opportunities,
directions
mentioned
final
section.
Pharmaceutics,
Год журнала:
2025,
Номер
17(1), С. 70 - 70
Опубликована: Янв. 7, 2025
Malignant
growth
is
expected
to
surpass
other
significant
causes
of
death
as
one
the
top
reasons
for
dismalness
and
mortality
worldwide.
According
a
World
Health
Organization
(WHO)
study,
this
illness
approximately
between
9
10
million
instances
deaths
annually.
Chemotherapy,
radiation,
surgery
are
three
main
methods
treating
cancer.
These
seek
completely
eradicate
all
cancer
cells
while
having
fewest
possible
unintended
impacts
on
healthy
cell
types.
Owing
lack
target
selectivity,
majority
medications
have
substantial
side
effects.
On
hand,
nanomaterials
transformed
identification,
diagnosis,
management
Nanostructures
with
biomimetic
properties
been
grown
late,
fully
intent
observing
sickness.
nanostructures
be
consumed
by
in
areas
profound
disease.
Furthermore,
because
their
extraordinary
physicochemical
properties,
which
incorporate
nanoscale
aspects,
more
prominent
surface
region,
explicit
geometrical
features,
ability
embody
different
substances
within
or
outside
surfaces,
remarkable
nano-vehicles
conveying
restorative
specialists
designated
regions.
This
review
discusses
recent
developments
nanostructured
materials
such
graphene,
dendrimers,
cell-penetrating
peptide
nanoparticles,
nanoliposomes,
lipid
magnetic
nano-omics
diagnosis
Polymers,
Год журнала:
2025,
Номер
17(4), С. 435 - 435
Опубликована: Фев. 7, 2025
Drug
delivery
systems
have
revolutionized
traditional
drug
administration
methods
by
addressing
various
challenges,
such
as
enhancing
solubility,
prolonging
effectiveness,
minimizing
adverse
effects,
and
preserving
potency.
Nanotechnology-based
systems,
particularly
nanoparticles
(NPs)
nanofibers
(NFs),
emerged
promising
solutions
for
biomedicine
delivery.
NFs,
with
their
ability
to
mimic
the
porous
fibrous
structures
of
biological
tissues,
garnered
significant
interest
in
drug-delivering
applications.
Biopolymers
gelatin
(Ge)
chitosan
(CH)
gained
much
more
attention
due
biocompatibility,
biodegradability,
versatility
biomedical
CH
exhibits
exceptional
anti-bacterial
activity,
wound
healing
capabilities,
whereas
Ge
provides
good
biocompatibility
cell
adhesion
properties.
Ge/CH-based
NFs
stimulate
cellular
connections
facilitate
tissue
regeneration
owing
structural
resemblance
extracellular
matrix.
This
review
explores
additive
preparation,
including
electrospinning,
force
pinning,
template
synthesis,
focusing
on
electrospinning
factors
influencing
fiber
structure.
The
properties
CH,
role
release,
formulation
strategies,
characterization
techniques
electrospun
fibers
are
discussed.
Furthermore,
this
addresses
applications
delivering
active
moieties
management
orthopedics
regulatory
considerations,
along
challenges
related
them.
Thus,
aims
provide
a
comprehensive
overview
potential
Molecules,
Год журнала:
2024,
Номер
29(10), С. 2393 - 2393
Опубликована: Май 19, 2024
The
rapid
advancements
in
nanotechnology
the
field
of
nanomedicine
have
potential
to
significantly
enhance
therapeutic
strategies
for
cancer
treatment.
There
is
considerable
promise
enhancing
efficacy
therapy
through
manufacture
innovative
nanocomposite
materials.
Metallic
nanoparticles
been
found
release
anticancer
medications
that
are
loaded
onto
them,
resulting
a
sustained
release,
hence
reducing
dosage
required
drug
administration
and
preventing
their
buildup
healthy
cells.
combination
with
biocompatible
materials
offers
new
prospects
development
advanced
therapies
exhibit
enhanced
selectivity,
reduced
adverse
effects,
improved
patient
outcomes.
Chitosan
(CS),
polysaccharide
possessing
distinct
physicochemical
properties,
exhibits
favorable
attributes
controlled
delivery
due
its
biocompatibility
biodegradability.
nanocomposites
heightened
stability,
biocompatibility,
prolonged
characteristics
medicines.
incorporation
gold
(Au)
into
chitosan
results
manifestation
photothermal
characteristics,
whereas
inclusion
silver
(Ag)
boosts
antibacterial
capabilities
synthesized
nanocomposite.
objective
this
review
investigate
recent
progress
utilization
Ag
Au
nanoparticles,
or
thereof,
within
matrix
modified
derivatives
purpose
delivery.
research
findings
deliver
various
drugs,
such
as
doxorubicin,
5-Fluroacil,
curcumin,
paclitaxel,
6-mercaptopurine,
were
investigated.
Moreover,
modifications
carried
out
on
phase
surfaces
targeting
loading
efficiency,
pH
sensitivity
highlighted.
In
addition,
challenges
perspectives
could
motivate
further
related
applications
summarized.
Journal of drug targeting,
Год журнала:
2025,
Номер
unknown, С. 1 - 28
Опубликована: Янв. 3, 2025
Breast
cancer
(BC)
is
a
substantial
reason
for
cancer-related
mortality
among
women
across
the
globe.
Anastrozole
(ANS)
an
effective
orally
administered
hormonal
therapy
estrogen+
(ER+)
BC
treatment.
However,
several
side
effects
and
pharmacokinetic
limitations
restricted
its
uses
in
Therefore,
this
study
developed
Pharmaceutics,
Год журнала:
2025,
Номер
17(2), С. 176 - 176
Опубликована: Янв. 30, 2025
Proton
therapy
represents
a
groundbreaking
advancement
in
cancer
radiotherapy,
leveraging
the
unique
spatial
energy
distribution
of
protons
to
deliver
precise,
high-dose
radiation
tumors
while
sparing
surrounding
healthy
tissues.
Despite
its
clinical
success,
proton
faces
challenges
optimizing
therapeutic
precision
and
efficacy.
Recent
research
has
highlighted
potential
gold
nanoparticles
enhance
outcomes.
Due
their
high
atomic
number
favorable
biological
properties,
act
as
radiosensitizers
by
amplifying
generation
secondary
electrons
reactive
oxygen
species
upon
irradiation.
This
enhances
DNA
damage
tumor
cells
preserving
Additionally,
functionalization
with
tumor-targeting
ligands
offers
improved
precision,
making
more
effective
against
broader
range
cancers.
review
synthesizes
current
knowledge
on
mechanisms
nanoparticle
radiosensitization,
preclinical
evidence,
technological
hurdles
that
must
be
addressed
integrate
this
promising
approach
into
practice,
aiming
advance
efficacy
accessibility
therapy.
European Journal of Pharmaceutics and Biopharmaceutics,
Год журнала:
2024,
Номер
201, С. 114349 - 114349
Опубликована: Июнь 5, 2024
Nanocarriers
have
demonstrated
promising
potential
in
the
delivery
of
various
anticancer
drugs
and
improving
efficiency
treatment.
In
this
study,
silver
nanoparticles
(AgNPs)
were
green-synthesized
using
extracts
different
parts
pomegranate
plant,
including
peel,
flower
petals,
calyx.
To
obtain
most
efficient
extract
used
for
green
synthesis
AgNPs,
all
three
types
synthesized
characterized.
Then,
(3-Aminopropyl)
triethoxysilane-functionalized
mesoporous
silica
(MSNs-APTES)
decorated
with
AgNPs
fabricated
via
a
one-pot
green-synthesis
method.
directly
coated
on
surface
MSNs-APTES
by
adding
enriched
source
reducing
agent
leading
to
converting
ion
AgNPs.
The
MSN-APTES-AgNPs
(MSNs-AgNPs)
been
thoroughly
characterized
nanoparticle
characterization
techniques.
addition,
DNA
cleavage
hemolysis
activities
analyzed,
confirming
biocompatibility
nanoparticles.
Doxorubicin
(DOX,
as
breast/cervical
anti-cancer
drug)
loading
(42.8%)
release
profiles
investigated
UV–visible
spectroscopy.
fibroblast,
breast
cancer,
cervical
cancer
cells'
viability
against
DOX-loaded
also
studied.
results
high
drug
loading,
uniform
shape,
small
functionalized
its
great
management.
Current Pharmaceutical Design,
Год журнала:
2024,
Номер
30(37), С. 2922 - 2936
Опубликована: Авг. 16, 2024
Solid
Lipid
Nanocarriers
(SLNs)
offer
a
promising
avenue
for
breast
cancer
treatment,
disease
that
accounts
12.5%
of
global
cases.
Despite
strides
in
combined
therapies
(surgery,
chemotherapy,
radiation,
and
endocrine
therapy),
challenges
like
systemic
toxicity,
drug
resistance,
adverse
effects
persist.
The
manuscript
offers
several
novel
contributions
to
the
field
treatment
through
use
SLNs,
these
are
innovative
delivery
systems,
multifunctionality,
biocompatibility,
potential
overcome
integration
with
emerging
therapies,
focus
on
personalized
medicine,
ongoing
future
research
directions
reduced
side
effects.
SLNs
present
strategy
due
their
unique
physicochemical
properties.
They
can
encapsulate
both
hydrophilic
hydrophobic
drugs,
ensuring
controlled
release
targeted
delivery,
thus
enhancing
solubility
bioavailability
reducing
multifunctional
nature
improves
while
biocompatibility
supports
therapy.
Challenges
pharmacists
include
maintaining
stability,
effective
loading,
timed
delivery.
Combining
gene
immunotherapy
holds
promise
more
treatments.
represent
significant
advancement,
providing
precise
fewer
effects,
overcoming
resistance.
Ongoing
will
refine
therapy,
targeting
cells
minimal
integrating
other
treatments
comprehensive
approaches.
Advances
nanotechnology
medicine
tailor
specific
subtypes,
effectiveness.
Clinical
trials
new
developments
crucial
realizing
SLNs'
full
care.
In
conclusion,
transformative
approach
addressing
issues
aims
optimize
potentially
revolutionizing
care
hope
patients.